New research highlights promising therapeutic interventions in respiratory and cardiovascular conditions. Biologic therapies reduce symptoms and hospitalizations in pulmonary arterial hypertension. Exercise programs facilitate immune recovery in post-COVID syndrome patients. Precision analysis of adiposity and inflammation links body composition to cardiometabolic risks and cardiovascular disease progression. Cutting-edge radiation approaches improve quality of life in lung and prostate cancer, while immune biomarkers offer prognostic information.